1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Golimumab
Trade Name:
Simponi
Manufacturer/Distributor:
Schering-Plough
www.schering-plough.ca, 1-800-463-5442 (Medical Information)
Classification:
Tumor necrosis factor alpha inhibitor (DMARD)
ATC Class:
L04AB06 Golimumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2009/04/07
Date Marketed in Canada (yyyy/mm/dd):
2009/07
Presentation:
Injection: 50 mg/0.5 mL; DIN 02324784
Comments:
To be used in combination with methotrexate in adult patients with moderate to severe rheumatoid arthritis. It can also be used alone or in combination with methotrexate for psoriatic arthritis. As well, patients with ankylosing spondylitis, who have had inadequate responses from conventional therapies, may benefit from use of golimumab.
Source:
Letter from company
